Liminatus Pharma Surges Over 5% After Announcing $500M BNB Investment Strategy
View all comments(0)
TradingKey – On Monday, July 28, Nasdaq-listed Liminatus Pharma Inc. (LIMN) jumped 5.28% in pre-market trading after unveiling plans to launch a dedicated crypto subsidiary focused on Binance Coin (BNB).

Liminatus Pharma Stock Chart – Source: Google
Liminatus, a preclinical-stage cancer immunotherapy company, announced it will form a new subsidiary called “American BNB Strategy” to manage and invest in BNB, the native token of the Binance ecosystem.
- The company aims to raise up to $500 million, deploying funds in phased investments targeting long-term BNB accumulation
- This move positions Liminatus alongside other corporate BNB holders like Nano Labs (NA), which currently holds 128,000 BNB
Coincidentally, the price of BNB soared above $850 today, setting a new record high. In the past 24 hours, BNB rose by more than 6%, reaching a high of $859 and temporarily reported at $849.

BNB price chart (1 hour), source: TradingView
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Google Q2 Cloud Revenue Surges 82%: Net Profit Soars 298% YoY, 26% QoQ Capital Expenditure Growth Sparks Sharp Bull-Bear Divide

Western Digital (WDC) Surges 12.5% to $548 - Kioxia Merger Talks, $900 Analyst Target

Alphabet Q2 Earnings Preview: $190 Billion AI Gamble Faces Major Test, Can Google Cloud Still Sustain the Growth Myth?

Micron (MU) Bounces to $969 - Morgan Stanley and BofA Both Say Buy the Dip

SpaceX Stock Price Forecast: SpaceX Short Bets Surge, Musk Warns Short Sellers May Pay the Price, Can the Stock Price See a Reversal?






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.